GlassScriptPhysician profile
Parissa Hagh
NPI 1922175835
$4,096.84
in general payments reported to CMS, 2019-2025
10 companies · $888 in 2025
The $888 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $197 · 2021: $658 · 2022: $551 · 2023: $617 · 2024: $318 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,523 · Consulting Fee: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,522.79 |
| Consulting Fee | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,837.78 | 2019-2025 | |
| Biogen, INC. | $570.00 | 2019-2025 | Tysabri, Skyclarys |
| Eisai INC. | $457.27 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $384.29 | 2019-2021 | |
| Sk Life Science, INC. | $215.70 | 2021-2023 | Xcopri |
| Neurelis, INC. | $203.12 | 2022-2024 | Valtoco |
| Acadia Pharmaceuticals INC | $121.83 | 2025 | Nuplazid |
| Amgen INC. | $121.82 | 2025 | Uplizna |
| Tg Therapeutics, INC. | $99.45 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $85.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parissa Hagh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.